Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells-Reference-Cited by-同舟云学术

Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells

Published:2020-05-14 Issue:7 Volume:17 Page:2463-2472
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Hembram Krushna Chandra¹,Dash Somya Ranjan¹,Das Biswajit¹,Sethy Chinmayee¹,Chatterjee Subhajit¹,Bindhani Birendra Kumar²,Kundu Chanakya Nath¹^ORCID

Affiliation:

1. Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Campus-11, Patia, Bhubaneswar, Odisha 751024, India

2. Plant Biotechnology and Nanotechnology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Campus-11, Patia, Bhubaneswar, Odisha 751024, India

Funder

Indian Council of Medical Research

Department of Biotechnology , Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00197

Reference42 articles.

1. Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014

2. A systematic analysis of FDA-approved anticancer drugs

3. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

4. Oral Cancer Stem Cells Microenvironment

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21;Medical Oncology;2024-06-04

2. Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells;Nanomedicine;2024-03

3. Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective;Pharmaceutics;2023-12-19

4. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300;Medical Oncology;2023-11-08

5. Talazoparib enhances the Quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300;2023-10-09